Applied Graphene Materials Group PLC (LON:AGM) is eyeing new product opportunities in the Asia markets after successfully completing a re-alignment of its business.
Intellectual property investment group Tekcapital PLC (LON:TEK) said its wholly-owned portfolio company Lucyd has filed five new patents and a trademark on its soon-to-be-launched line of Bluetooth audio glasses.
ClearStar Inc (LON:CLSU) said its order book is at the “highest ever” level, with a “healthy” pipeline for further orders next year, while the background and medical screening group said adjusted underlying earnings for the current year will come in at US$300,000.
Sareum Holdings PLC has reiterated its plans to focus on the development of its TYK2/JAK1 programmes: SDC-1801, for autoimmune diseases, and SDC-1802, targeting cancer.
Ariana Resources PLC (LON:AAU) has revealed its latest drilling results from resource drilling at the producing Kiziltepe mine in Turkey. Among the highlights of drilling testing for deeper extensions at Arzu South were 16 metres at 2.04 grams per tonne gold and 67 grams silver, and three metres at 6.25 grams and 129 grams silver.
Bluebird Merchant Ventures Ltd (LON:BMV) has received a permit to develop the Kochang mine in South Korea. Production is now expected in 2020, with the potential to grow from an initial rate of 10,000 ounces per year to 30,000 ounces over three years.
Alien Metals Ltd (LON:UFO) has completed an initial review of data supplied by Karratha Metals Group in relation to the acquisition of the Elizabeth Hill silver project in Western Australia. Alien signed an option to acquire Elizabeth Hill on 4 December 2019.
Anglo Pacific Group PLC’s (LON:APF) company secretary Kevin Flynn is set to become an executive director on 1 January 2020, a move that “formalises the role that he has been undertaking for the past number of years”.
Silence Therapeutics PLC (LON:SLN) has appointed Iain Ross as executive chairman from the start of next year with chief executive David Horn Solomon to shift his focus towards the US.
Kromek (LON:KMK) non-executive director Christopher Wilks yesterday bought 50,000 ordinary shares in the company at a price of 21.95p apiece, for a total of £10,975 plus costs.
The Vulpes Life Science Fund has increased its stake in Scancell Holdings PLC (LON:SCLP) with the purchase of 2.925mln shares at a price of 5.2p this week, following which it now owns 80.55mln shares or 17.3% of the company.